ℹ️
🇬🇧
Search
Search for publications relevant for "volume loss"
volume loss
Publication
Class
Person
Publication
Programmes
publication
Anterior hippocampus volume loss in narcolepsy with cataplexy
2019 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
Hippocampal but not amygdalar volume loss in narcolepsy with cataplexy
2015 |
First Faculty of Medicine
publication
Pathological cut-offs of global and regional brain volume loss in multiple sclerosis
2019 |
First Faculty of Medicine
publication
Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis
2021 |
First Faculty of Medicine
publication
Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis
2021 |
First Faculty of Medicine
publication
Pregnancy-induced brain magnetic resonance imaging changes in women with multiple sclerosis
2022 |
First Faculty of Medicine
publication
"No evident disease activity": The use of combined assessments in the management of patients with multiple sclerosis
2017 |
First Faculty of Medicine
publication
Ductile deformation of tonalite in the Suomusjärvi shear zone, south-western Finland
1998 |
Faculty of Science
publication
Spatial navigation impairment is proportional to right hippocampal volume
2012 |
First Faculty of Medicine
publication
Amygdala and emotionality in Parkinson's disease: An integrative review of the neuropsychological evidence
2018 |
Central Library of Charles University
publication
Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis
2021 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis
2021 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
SARS-CoV-2 RNA in the Cerebrospinal Fluid of a Patient with Long COVID
2021 |
Faculty of Medicine in Hradec Králové
publication
Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine
2016 |
First Faculty of Medicine
publication
Magnetic resonance analysis of amygdalar volume in Alzheimer's disease
2007 |
First Faculty of Medicine, Second Faculty of Medicine
publication
In vivo study on biodegradable magnesium alloys: Bone healing around WE43 screws
2018 |
First Faculty of Medicine
publication
Learning deficits in aged rats related to decrease in extracellular volume and loss of difussion anisotropy in hippocampus
2002 |
Second Faculty of Medicine
publication
Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later
2016 |
First Faculty of Medicine
publication
Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?
2017 |
First Faculty of Medicine
publication
Three-dimensional centrifuge and numerical modeling of the interaction between perpendicularly crossing tunnels
2013 |
Faculty of Science
publication
SENIOR'S MOVEMENT ACTIVITIES - BENEFITS AND PROBLEMS
+1
2012 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
Influences of Shielding of Multi-crossing Tunnels on Ground Displacement
2016 |
Faculty of Science
publication
Presence of brainstem lesions is associated with diffuse spinal cord abnormalities in patients with early multiple sclerosis
Publication without faculty affiliation
publication
Time course of lesion-induced atrophy in multiple sclerosis
2022 |
First Faculty of Medicine
publication
Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study A Randomized Clinical Trial
2021 |
First Faculty of Medicine
publication
Spatial navigation impairment is proportional to right hippocampal volume
2012 |
Second Faculty of Medicine
publication
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon beta-1a in MS
2016 |
First Faculty of Medicine
publication
Understanding the positive benefit: risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program
2017 |
First Faculty of Medicine, Second Faculty of Medicine
publication
A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study
2017 |
First Faculty of Medicine